SciDevL (SDV) Q4 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 TU earnings summary
13 Jun, 2025Executive summary
Achieved record quarterly revenue of $29.9m in Q4 FY24, up 56% year-over-year, and record annual revenue of $109.3m, up 22% from FY23.
Underlying EBITDA for FY24 reached $8.9m, a 118% increase over FY23, with positive operating cash flow of $6.5m for the year.
Growth driven by expanding client base, strong demand for proprietary PFAS-remediation technology, and enhanced operational efficiency.
Financial highlights
Q4 FY24 group revenue: $29.9m (+56% vs Q4 FY23); cash receipts: $32.6m.
Q4 FY24 operating cash flow: $2.2m; cash and cash equivalents at 30 June 2024: $9.4m.
FY24 unaudited underlying EBITDA: $8.9m (+118% vs FY23); annual revenue: $109.3m (+22% vs FY23).
Inventory at quarter end: $7.4m.
Outlook and guidance
Positioned for continued growth in FY25, focusing on health and safety, capitalizing on new PFAS regulations, and expanding in mining and oil & gas markets.
Plans to leverage proprietary technologies and joint ventures for global expansion, especially in North America and Europe.
Targeting further diversification and sustainable growth through business development and new contracts.
Latest events from SciDevL
- Revenue and EBITDA declined, but recurring revenue and cost actions support future growth.SDV
H1 202625 Feb 2026 - EBITDA rose to $3.4m on steady $49.9m revenue, with strong cash and PFAS-driven growth outlook.SDV
H1 202526 Dec 2025 - $103m revenue, margin gains, and global PFAS growth set up strong FY 2026 outlook.SDV
H2 202523 Nov 2025 - Revenue and EBITDA surged, with strategic US wins and strong demand despite market volatility.SDV
Q3 2025 TU16 Jun 2025 - FY24 saw double-digit growth and strategic expansion in water, mining, and PFAS solutions.SDV
AGM 2024 Presentation13 Jun 2025 - Q1 FY25 saw 21% revenue growth, 286% EBITDA increase, and robust cash flow.SDV
Q1 2025 TU13 Jun 2025 - Record revenue, profit, and cash flow position SciDev for continued growth in FY25.SDV
H2 202413 Jun 2025